SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-003880
Filing Date
2023-01-19
Accepted
2023-01-19 20:29:20
Documents
2
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3927
2 POWER OF ATTORNEY ea167205ex24-1_cadrenal.htm EX-24.1 6954
  Complete submission text file 0001213900-23-003880.txt   12197
Mailing Address 2483 NE JULEP STREET ISSAQUAH WA 98029
Business Address
WILSON GLYNN (Reporting) CIK: 0001405625 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41596 | Film No.: 23538720

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations